NBP255698PE

Novus Biologicals™ TAF3 Recombinant Protein Antigen

Manufacturer: Novus Biologicals™

Select a Size

Pack Size SKU Availability Price
Each of 1 NBP255698PE-Each-of-1 In Stock ₹ 31,372.50

NBP255698PE - Each of 1

₹ 31,372.50

In Stock

Quantity

1

Base Price: ₹ 31,372.50

GST (18%): ₹ 5,647.05

Total Price: ₹ 37,019.55

Gene ID (Entrez)

83860

Common Name

TAF3 Recombinant Protein Antigen

Formulation

PBS and 1M Urea, pH 7.4.

Gene Alias

140 kDa TATA box-binding protein-associated factor, MGC25063, RNA polymerase II transcription factor TAFII140, TAF(II)140, TAF140, TAF3 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 140kDa, TAFII140, TAFII-140, TBP-associated factor

Label Type

Unlabeled

Quantity

100μL

Source

E.Coli

Purification Method

>80% by SDS-PAGE and Coomassie blue staining

Content And Storage

Store at −20C. Avoid freeze-thaw cycles.

For Use With (Application)

Blocking/Neutralizing, Control

Gene Symbol

TAF3

Product Type

Recombinant Protein Antigen

Regulatory Status

RUO

Specific Reactivity

This recombinant antigen is only intended to be used as a blocking agent to confirm antibody specificity with the corresponding antibody, catalog number NBP2-52934. It is purified by IMAC chromatography, and the expected concentration is greater than 0.5 mg/ml

Related Products

Img

Novus Biologicals™

NBP255367PE

--

Img

Novus Biologicals™

NBP255931PE

--

Img

Novus Biologicals™

NBP255326PE

--

Img

Novus Biologicals™

NBP255101PE

--

Img

Novus Biologicals™

NBP256300PE

--

Img

Novus Biologicals™

NBP255864PE

--

Img

Novus Biologicals™

NBP255776PE

--

Img

Novus Biologicals™

NBP255564PE

--

Description

  • A recombinant protein antigen with a N-terminal His6-ABP tag corresponding to human TAF3
  • Source: E.coli Amino Acid Sequence: ENFLGKRPLDSPEAEELPAMKRPRLLSTKGDTLDVVLLEAREPLSSINTQKIPPMLSPVHVQDSTDLAPPSPEPPMLAPVAKSQMPTAKPLETKSFTPKTKTKTSSPGQKTKSPKTAQSPAMVGSP The TAF3 Recombinant Protein Antigen is derived from E
  • coli
  • The TAF3 Recombinant Protein Antigen has been validated for the following applications: Antibody Competition.